Global Nano-Drug Sales Market Report 2021

1 Nano-Drug Market Overview

• 1.1 Nano-Drug Product Scope
• 1.2 Nano-Drug Segment by Type
  • 1.2.1 Global Nano-Drug Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Liposomes
  • 1.2.3 Polymeric Micelles
  • 1.2.4 Solid lipid Nanoparticles
  • 1.2.5 Microemulsion and Nanoemulsion
  • 1.2.6 Nanosuspension
• 1.3 Nano-Drug Segment by Application
  • 1.3.1 Global Nano-Drug Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Cancer and Tumors
  • 1.3.3 Autoimmune Disorders
• 1.4 Nano-Drug Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Nano-Drug Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Nano-Drug Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Nano-Drug Price Trends (2016-2027)

2 Nano-Drug Estimates and Forecasts by Region

• 2.1 Global Nano-Drug Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Nano-Drug Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Nano-Drug Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Nano-Drug Revenue Market Share by Region (2016-2021)
• 2.3 Global Nano-Drug Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Nano-Drug Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Nano-Drug Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Nano-Drug Estimates and Projections (2016-2027)
  • 2.4.2 Europe Nano-Drug Estimates and Projections (2016-2027)
  • 2.4.3 China Nano-Drug Estimates and Projections (2016-2027)
  • 2.4.4 Japan Nano-Drug Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Nano-Drug Estimates and Projections (2016-2027)
  • 2.4.6 India Nano-Drug Estimates and Projections (2016-2027)

3 Global Nano-Drug Competition Landscape by Players

• 3.1 Global Top Nano-Drug Players by Sales (2016-2021)
• 3.2 Global Top Nano-Drug Players by Revenue (2016-2021)
• 3.3 Global Nano-Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nano-Drug as of 2020)
• 3.4 Global Nano-Drug Average Price by Company (2016-2021)
• 3.5 Manufacturers Nano-Drug Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Nano-Drug Market Size by Type

• 4.1 Global Nano-Drug Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Nano-Drug Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Nano-Drug Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Nano-Drug Price by Type (2016-2021)
• 4.2 Global Nano-Drug Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Nano-Drug Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Nano-Drug Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Nano-Drug Price Forecast by Type (2022-2027)

5 Global Nano-Drug Market Size by Application

• 5.1 Global Nano-Drug Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Nano-Drug Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Nano-Drug Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Nano-Drug Price by Application (2016-2021)
• 5.2 Global Nano-Drug Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Nano-Drug Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Nano-Drug Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Nano-Drug Price Forecast by Application (2022-2027)

6 North America Nano-Drug Market Facts & Figures

• 6.1 North America Nano-Drug Sales by Company
  • 6.1.1 North America Nano-Drug Sales by Company (2016-2021)
  • 6.1.2 North America Nano-Drug Revenue by Company (2016-2021)
• 6.2 North America Nano-Drug Sales Breakdown by Type
  • 6.2.1 North America Nano-Drug Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Nano-Drug Sales Breakdown by Type (2022-2027)
• 6.3 North America Nano-Drug Sales Breakdown by Application
  • 6.3.1 North America Nano-Drug Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Nano-Drug Sales Breakdown by Application (2022-2027)

7 Europe Nano-Drug Market Facts & Figures

• 7.1 Europe Nano-Drug Sales by Company
  • 7.1.1 Europe Nano-Drug Sales by Company (2016-2021)
  • 7.1.2 Europe Nano-Drug Revenue by Company (2016-2021)
• 7.2 Europe Nano-Drug Sales Breakdown by Type
  • 7.2.1 Europe Nano-Drug Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Nano-Drug Sales Breakdown by Type (2022-2027)
• 7.3 Europe Nano-Drug Sales Breakdown by Application
  • 7.3.1 Europe 151 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 151 Sales Breakdown by Application (2022-2027)

8 China Nano-Drug Market Facts & Figures

• 8.1 China Nano-Drug Sales by Company
  • 8.1.1 China Nano-Drug Sales by Company (2016-2021)
  • 8.1.2 China Nano-Drug Revenue by Company (2016-2021)
• 8.2 China Nano-Drug Sales Breakdown by Type
  • 8.2.1 China Nano-Drug Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Nano-Drug Sales Breakdown by Type (2022-2027)
• 8.3 China Nano-Drug Sales Breakdown by Application
  • 8.3.1 China 171 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 171 Sales Breakdown by Application (2022-2027)

9 Japan Nano-Drug Market Facts & Figures

• 9.1 Japan Nano-Drug Sales by Company
  • 9.1.1 Japan Nano-Drug Sales by Company (2016-2021)
  • 9.1.2 Japan Nano-Drug Revenue by Company (2016-2021)
• 9.2 Japan Nano-Drug Sales Breakdown by Type
  • 9.2.1 Japan Nano-Drug Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Nano-Drug Sales Breakdown by Type (2022-2027)
• 9.3 Japan Nano-Drug Sales Breakdown by Application
  • 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Nano-Drug Market Facts & Figures

• 10.1 Southeast Asia Nano-Drug Sales by Company
  • 10.1.1 Southeast Asia Nano-Drug Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Nano-Drug Revenue by Company (2016-2021)
• 10.2 Southeast Asia Nano-Drug Sales Breakdown by Type
  • 10.2.1 Southeast Asia Nano-Drug Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Nano-Drug Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Nano-Drug Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Doses Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Doses Sales Breakdown by Application (2022-2027)

11 India Nano-Drug Market Facts & Figures

• 11.1 India Nano-Drug Sales by Company
  • 11.1.1 India Nano-Drug Sales by Company (2016-2021)
  • 11.1.2 India Nano-Drug Revenue by Company (2016-2021)
• 11.2 India Nano-Drug Sales Breakdown by Type
  • 11.2.1 India Nano-Drug Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Nano-Drug Sales Breakdown by Type (2022-2027)
• 11.3 India Nano-Drug Sales Breakdown by Application
  • 11.3.1 India Nano-Drug Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Nano-Drug Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Nano-Drug Business

• 12.1 Merck
  • 12.1.1 Merck Corporation Information
  • 12.1.2 Merck Business Overview
  • 12.1.3 Merck Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Merck Nano-Drug Products Offered
  • 12.1.5 Merck Recent Development
• 12.2 Pfizer
  • 12.2.1 Pfizer Corporation Information
  • 12.2.2 Pfizer Business Overview
  • 12.2.3 Pfizer Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Pfizer Nano-Drug Products Offered
  • 12.2.5 Pfizer Recent Development
• 12.3 Novartis
  • 12.3.1 Novartis Corporation Information
  • 12.3.2 Novartis Business Overview
  • 12.3.3 Novartis Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Novartis Nano-Drug Products Offered
  • 12.3.5 Novartis Recent Development
• 12.4 Abbott
  • 12.4.1 Abbott Corporation Information
  • 12.4.2 Abbott Business Overview
  • 12.4.3 Abbott Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Abbott Nano-Drug Products Offered
  • 12.4.5 Abbott Recent Development
• 12.5 GlaxoSmithKline
  • 12.5.1 GlaxoSmithKline Corporation Information
  • 12.5.2 GlaxoSmithKline Business Overview
  • 12.5.3 GlaxoSmithKline Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 GlaxoSmithKline Nano-Drug Products Offered
  • 12.5.5 GlaxoSmithKline Recent Development
• 12.6 Roche
  • 12.6.1 Roche Corporation Information
  • 12.6.2 Roche Business Overview
  • 12.6.3 Roche Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Roche Nano-Drug Products Offered
  • 12.6.5 Roche Recent Development
• 12.7 Sanofi
  • 12.7.1 Sanofi Corporation Information
  • 12.7.2 Sanofi Business Overview
  • 12.7.3 Sanofi Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Sanofi Nano-Drug Products Offered
  • 12.7.5 Sanofi Recent Development
• 12.8 Eli Lilly
  • 12.8.1 Eli Lilly Corporation Information
  • 12.8.2 Eli Lilly Business Overview
  • 12.8.3 Eli Lilly Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Eli Lilly Nano-Drug Products Offered
  • 12.8.5 Eli Lilly Recent Development
• 12.9 Astrazeneca
  • 12.9.1 Astrazeneca Corporation Information
  • 12.9.2 Astrazeneca Business Overview
  • 12.9.3 Astrazeneca Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Astrazeneca Nano-Drug Products Offered
  • 12.9.5 Astrazeneca Recent Development
• 12.10 Johnson & Johnson
  • 12.10.1 Johnson & Johnson Corporation Information
  • 12.10.2 Johnson & Johnson Business Overview
  • 12.10.3 Johnson & Johnson Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Johnson & Johnson Nano-Drug Products Offered
  • 12.10.5 Johnson & Johnson Recent Development
• 12.11 Celgene
  • 12.11.1 Celgene Corporation Information
  • 12.11.2 Celgene Business Overview
  • 12.11.3 Celgene Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 Celgene Nano-Drug Products Offered
  • 12.11.5 Celgene Recent Development
• 12.12 Novavax
  • 12.12.1 Novavax Corporation Information
  • 12.12.2 Novavax Business Overview
  • 12.12.3 Novavax Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.12.4 Novavax Nano-Drug Products Offered
  • 12.12.5 Novavax Recent Development
• 12.13 Stryker
  • 12.13.1 Stryker Corporation Information
  • 12.13.2 Stryker Business Overview
  • 12.13.3 Stryker Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.13.4 Stryker Nano-Drug Products Offered
  • 12.13.5 Stryker Recent Development
• 12.14 Gilead Sciences
  • 12.14.1 Gilead Sciences Corporation Information
  • 12.14.2 Gilead Sciences Business Overview
  • 12.14.3 Gilead Sciences Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.14.4 Gilead Sciences Nano-Drug Products Offered
  • 12.14.5 Gilead Sciences Recent Development
• 12.15 OSI Pharmaceuticals
  • 12.15.1 OSI Pharmaceuticals Corporation Information
  • 12.15.2 OSI Pharmaceuticals Business Overview
  • 12.15.3 OSI Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.15.4 OSI Pharmaceuticals Nano-Drug Products Offered
  • 12.15.5 OSI Pharmaceuticals Recent Development
• 12.16 Kadmon Pharmaceuticals
  • 12.16.1 Kadmon Pharmaceuticals Corporation Information
  • 12.16.2 Kadmon Pharmaceuticals Business Overview
  • 12.16.3 Kadmon Pharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.16.4 Kadmon Pharmaceuticals Nano-Drug Products Offered
  • 12.16.5 Kadmon Pharmaceuticals Recent Development
• 12.17 Samyang Biopharm
  • 12.17.1 Samyang Biopharm Corporation Information
  • 12.17.2 Samyang Biopharm Business Overview
  • 12.17.3 Samyang Biopharm Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.17.4 Samyang Biopharm Nano-Drug Products Offered
  • 12.17.5 Samyang Biopharm Recent Development
• 12.18 Mitsubishi Pharma
  • 12.18.1 Mitsubishi Pharma Corporation Information
  • 12.18.2 Mitsubishi Pharma Business Overview
  • 12.18.3 Mitsubishi Pharma Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.18.4 Mitsubishi Pharma Nano-Drug Products Offered
  • 12.18.5 Mitsubishi Pharma Recent Development
• 12.19 Kaken Pharmaceutical
  • 12.19.1 Kaken Pharmaceutical Corporation Information
  • 12.19.2 Kaken Pharmaceutical Business Overview
  • 12.19.3 Kaken Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.19.4 Kaken Pharmaceutical Nano-Drug Products Offered
  • 12.19.5 Kaken Pharmaceutical Recent Development
• 12.20 Selecta Biosciences
  • 12.20.1 Selecta Biosciences Corporation Information
  • 12.20.2 Selecta Biosciences Business Overview
  • 12.20.3 Selecta Biosciences Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.20.4 Selecta Biosciences Nano-Drug Products Offered
  • 12.20.5 Selecta Biosciences Recent Development
• 12.21 Par Pharmaceutical
  • 12.21.1 Par Pharmaceutical Corporation Information
  • 12.21.2 Par Pharmaceutical Business Overview
  • 12.21.3 Par Pharmaceutical Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.21.4 Par Pharmaceutical Nano-Drug Products Offered
  • 12.21.5 Par Pharmaceutical Recent Development
• 12.22 Cerulean Pharma
  • 12.22.1 Cerulean Pharma Corporation Information
  • 12.22.2 Cerulean Pharma Business Overview
  • 12.22.3 Cerulean Pharma Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.22.4 Cerulean Pharma Nano-Drug Products Offered
  • 12.22.5 Cerulean Pharma Recent Development
• 12.23 Navidea Biopharmaceuticals
  • 12.23.1 Navidea Biopharmaceuticals Corporation Information
  • 12.23.2 Navidea Biopharmaceuticals Business Overview
  • 12.23.3 Navidea Biopharmaceuticals Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.23.4 Navidea Biopharmaceuticals Nano-Drug Products Offered
  • 12.23.5 Navidea Biopharmaceuticals Recent Development
• 12.24 Lummy
  • 12.24.1 Lummy Corporation Information
  • 12.24.2 Lummy Business Overview
  • 12.24.3 Lummy Nano-Drug Sales, Revenue and Gross Margin (2016-2021)
  • 12.24.4 Lummy Nano-Drug Products Offered
  • 12.24.5 Lummy Recent Development

13 Nano-Drug Manufacturing Cost Analysis

• 13.1 Nano-Drug Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Nano-Drug
• 13.4 Nano-Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Nano-Drug Distributors List
• 14.3 Nano-Drug Customers

15 Market Dynamics

• 15.1 Nano-Drug Market Trends
• 15.2 Nano-Drug Drivers
• 15.3 Nano-Drug Market Challenges
• 15.4 Nano-Drug Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List